Results 1 to 10 of about 283,224 (387)
Application of chemotherapy combined with immunotherapy in first-line treatment of advanced esophageal cancer: fluorouracil or paclitaxel? – a meta-analysis [PDF]
Frontiers in OncologyIntroductionImmunotherapy combined with chemotherapy is now the first-line standard for metastatic/recurrent esophageal cancer, with rapid immunotherapy advancements significantly improving patient outcomes.
Xiaochen Chen +4 more
doaj +2 more sources
Fluorouracil cardiotoxicity. [PDF]
BMJ, 1978 Our of 140 patients treated with intravenous 5-fluorouracil, four developed ischaemic chest pain within 18 hours of either the second or third dose. In three of these patients the pain recurred after subsequent doses. Predose electrocardiograms in two cases were normal.
A, Pottage +3 more
+9 more sources
A Pilot Study of Peritumor Administration of 5-FU for Preventing Bleeding in Advanced Gastric Cancer
The Korean Journal of Gastroenterology, 2022 Five-FU is a potent chemotherapeutic agent for suppressing endothelial cell growth. The purpose of this study was to investigate the usefulness of local peritumor injection of 5-FU for patients with advanced gastric cancer (AGC) for the prevention of ...
Nam-Hee Kim +4 more
doaj +1 more source
Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report
Case Reports in Oncology, 2021 We had previously reported on S-1-induced hypertriglyceridemia. Here, we report fluorouracil-induced hypertriglyceridemia in a patient with capecitabine-induced hypertriglyceridemia and the corresponding therapeutic process.
Yoshitaka Saito +4 more
doaj +1 more source
PHYSIOLOGICAL AND BIOCHEMICAL CHANGES FOR 5- FLUOROURACIL DRUG (ANTI-CANCER) IN CANCER PATIENTS [PDF]
Basrah Journal of Veterinary Research, 2017 The study was conducted to determine the effect of the 5-Fluorouracil (5-FU) drug is a medication used to treat cancer or the knowledge of 5-FU drug(anticancer) effect might help to attribute these side on physiological and biochemical parameters in ...
Baida R. Ali
doaj +1 more source
Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil [PDF]
Japanese Journal of Cancer Research, 1992 The CMF‐regimen is amongst the most effective chemotherapeutic approaches in the treatment of breast cancer. It is generally accepted that the efficacy of the combination of the three agents used in the regimen, i.e., cyclophosphamide (CY), methotrexate (MTX) and fluorouracil (FUra), is based on interactions between the drugs at the intratumoral level.
Ernst A. De Bruijn +3 more
openaire +3 more sources
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
Molecular Therapy: Oncolytics, 2021 Advanced pancreatic cancer is characterized by few treatment options and poor outcomes. Oncolytic virotherapy and chemotherapy involve complementary pharmacodynamics and could synergize to improve therapeutic efficacy.
Hans Martin Singh +10 more
doaj +1 more source
Frontiers in Oncology, 2022 Approximately 85% of lung cancer cases are non-small-cell lung cancer (NSCLC). Chemoresistance is a leading cause of chemotherapy failure in NSCLC treatment.
Li Li +6 more
doaj +1 more source
Cancer Reports, 2022 Background The standard chemotherapy treatment protocol for patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) requires as long as 56 days of hospitalization over six months. Where the 5‐Fluorouracil (5‐FU) pump is available,
Amichay Meirovitz +7 more
doaj +1 more source
Chondrosarcoma of Ureter in an Elderly Patient: A Case Report
Medicina, 2023 Chondrosarcoma is a rare type of cancer that can affect the upper urinary tract. Because of its rarity, the clinical presentation of chondrosarcoma can be similar to other urinary tract conditions, such as renal colic, hematuria, and urothelial carcinoma.
Szu-Ying Pan +7 more
doaj +1 more source